Q3 2020 Holdings
Filed 2020-11-13 | 137 holdings | $809.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $257.8M | 900,000 | 31.9% |
| Alibaba Group Hldg LTD(BABA) | SPONSORED ADS | 01609W102 | $124.9M | 425,000 | 15.4% |
| Biontech SE(BNTX) | SPONSORED ADS | 09075V102 | $119.9M | 1,731,214 | 14.8% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $116.5M | 800,000 | 14.4% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $85.1M | 324,200 | 10.5% |
| Black Diamond Therapeutics I(BDTX) | COM | 09203E105 | $46.0M | 1,521,517 | 5.7% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $15.0M | 400,000 | 1.9% |
| Aurinia Pharmaceuticals Inc(AUPH) | COM | 05156V102 | $14.7M | 1,000,000 | 1.8% |
| Cardiff Oncology Inc(CRDF) | COM | 14147L108 | $12.8M | 900,000 | 1.6% |
| Adaptive Biotechnologies COR(ADPT) | COM | 00650F109 | $4.9M | 100,000 | 0.6% |
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $3.8M | 100,000 | 0.5% |
| Autolus Therapeutics PLC(AUTL) | SPONSORED ADS | 05280R100 | $3.3M | 285,000 | 0.4% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $1.2M | 178,600 | 0.1% |
| Invesco QQQ TR(QQQ)Put | UNIT SER 1 | 46090E103 | $571.8K | 2,058,000 | 0.1% |
| WW Intl Inc(WW6) | COM | 98262P101 | $279.6K | 14,818,300 | 0.0% |
| Goldman Sachs Group Inc(GS)Call | COM | 38141G104 | $175.8K | 875,000 | 0.0% |
| Acceleron Pharma Inc(XLRN) | COM | 00434H108 | $157.5K | 1,400,000 | 0.0% |
| JPMorgan Chase & Co(JPM)Call | COM | 46625H100 | $96.3K | 1,000,000 | 0.0% |
| Generation BIO Co(GBIOGBX) | COM | 37148K100 | $87.0K | 2,814,191 | 0.0% |
| Lexicon Pharmaceuticals Inc(LXRX) | COM NEW | 528872302 | $86.7K | 60,240,864 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $83.0K | 500,000 | 0.0% |
| GDS Hldgs LTD(GDS) | SPONSORED ADS | 36165L108 | $81.8K | 1,000,000 | 0.0% |
| Allovir Inc | COM | 019818103 | $63.9K | 2,323,371 | 0.0% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $60.0K | 1,500,000 | 0.0% |
| KE Hldgs Inc(BEKE) | SPONSORED ADS | 482497104 | $53.3K | 870,000 | 0.0% |
| IGM Biosciences Inc(1K0) | COM | 449585108 | $50.8K | 688,910 | 0.0% |
| BK of America Corp(BAC)Call | COM | 060505104 | $48.2K | 2,000,000 | 0.0% |
| Morphic Hldg Inc | COM | 61775R105 | $45.2K | 1,651,686 | 0.0% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $44.1K | 2,495,140 | 0.0% |
| Abbvie Inc(ABBV)Call | COM | 00287Y109 | $43.8K | 500,000 | 0.0% |
| Schrodinger Inc(SDGR) | COM | 80810D103 | $42.6K | 897,445 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $42.4K | 3,000,000 | 0.0% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $40.1K | 1,500,000 | 0.0% |
| Select Sector Spdr TR(XLI)Call | SBI INT-INDS | 81369Y704 | $38.5K | 500,000 | 0.0% |
| I MAB(NBP) | SPONSORED ADS | 44975P103 | $34.1K | 725,000 | 0.0% |
| Novagold RES Inc(NG) | COM NEW | 66987E206 | $30.9K | 2,600,000 | 0.0% |
| Deciphera Pharmaceuticals in(DCPHEUR) | COM | 24344T101 | $30.8K | 600,000 | 0.0% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $29.3K | 2,358,968 | 0.0% |
| Atara Biotherapeutics Inc(ATRAGBX) | COM | 046513107 | $29.2K | 2,250,000 | 0.0% |
| Albireo Pharma Inc(BDQM) | COM | 01345P106 | $28.4K | 851,405 | 0.0% |
| Turning Point Therapeutics I | COM | 90041T108 | $28.4K | 325,000 | 0.0% |
| Uniqure NV(QURE) | SHS | N90064101 | $27.6K | 750,000 | 0.0% |
| Agenus Inc(AGENEUR) | COM NEW | 00847G705 | $27.6K | 6,900,000 | 0.0% |
| Iteos Therapeutics Inc(5E7) | COM | 46565G104 | $27.0K | 1,094,047 | 0.0% |
| Taysha Gene Therapies Inc(TSHA) | COM SHS | 877619106 | $25.6K | 1,140,882 | 0.0% |
| Morgan Stanley(MS)Call | COM NEW | 617446448 | $24.2K | 500,000 | 0.0% |
| Apple Inc(AAPL)Call | COM | 037833100 | $23.2K | 200,000 | 0.0% |
| Citigroup Inc(C)Call | COM NEW | 172967424 | $21.6K | 500,000 | 0.0% |
| Trillium Therapeutics Inc | COM NEW | 89620X506 | $21.3K | 1,500,000 | 0.0% |
| Moderna Inc(MRNA) | COM | 60770K107 | $21.2K | 300,000 | 0.0% |